Results 121 to 130 of about 24,341 (292)

Long‐Term Prognosis of Ischemic Stroke in Young Adults—A Single‐Center Chinese Cohort Study

Brain and Behavior, Volume 15, Issue 4, April 2025.
The long‐term prognosis and identified risk factors associated with recurrent ischemic cerebrovascular events and unfavorable functional outcome in a single‐center cohort of young patients with ischemic stroke. ABSTRACT Introduction Young patients with ischemic stroke often present with more complex etiologies and risk factors, making their long‐term ...
Yuhui Sha, Qiqi Wang, Mingyu Tang, Ming Yao, Yicheng Zhu, Lixin Zhou, Jun Ni   +6 more
wiley   +1 more source

Hemolytic uremic syndrome and IgA nephropathy in a child: Coincidence or not?

The Turkish Journal of Pediatrics, 2018
A previously healthy 18-month old boy, presenting with diarrhea, anemia, thrombocytopenia and acute renal failure was admitted to our hospital. Hemolytic uremic syndrome (HUS) was diagnosed with his clinical and laboratory findings.
Serra Sürmeli-Döven, Ali Delibaş, İclal Gürses, Uğur Raşit Kayacan, Banu Coşkun-Yılmaz, Kaan Esen, Emine Korkmaz, Fatih Özaltın   +7 more
doaj   +1 more source

Difficulties in diagnosing atypical hemolytic uremic syndrome

Сибирский научный медицинский журнал, 2020
The paper presents the case of clinical observation of a patient with atypical hemolytic-uremic syndrome (aHUS). aHUS is a disease characterized by an unfavorable prognosis (severe or catastrophic course with rapid development of terminal renal or multi ...
N. V. Fomina, L. D. Chesnokova, O. A. Konderova, S. A. Smakotina, E. V. Utkina, V. Yu. Isaev   +5 more
doaj   +1 more source

Eculizumab for Gemcitabine-Induced Hemolytic Uremic Syndrome: A Novel Therapy for an Emerging Condition [PDF]

, 2015
Introduction Atypical hemolytic uremic syndrome (aHUS), a thrombotic microangiopathy (TMA), is a disease characterized by hemolytic anemia, thrombocytopenia, and renal impairment. Gemcitabine, a commonly used chemotherapy, is emerging as a cause of aHUS.
Karkowsky, MD, Raphael, Parikh, MD, Kinjal   +1 more
core   +2 more sources

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

BMC Nephrology, 2019
BackgroundThere are limited long-term outcome data in eculizumab-treated patients with atypical hemolytic uremic syndrome (aHUS). We report final results from the largest prospective, observational, multicenter study of patients with aHUS treated with ...
J. Menne, Yahsou Delmas, F. Fakhouri, C. Licht, Åsa Lommelé, E. Minetti, F. Provôt, E. Rondeau, N. Sheerin, Jimmy Wang, L. Weekers, L. Greenbaum   +11 more
semanticscholar   +1 more source

A Thrombocytopenic Thrombotic Purpura in a Patient With a Metastatic HER2+ Breast Cancer: Description of a Case Report

Clinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Paraneoplastic (p) TTP is a rare syndrome characterized by an immune‐induced, generalized microangiopathy associated with solid or hematological tumors. This case, reporting a patient with a metastatic HER2+ breast cancer and a pTTP, highlights the rarity of this entity, its difficult and challenging diagnosis, and the complexity of its ...
Raffaele Longo, Benjamin Savenkoff, Romane Ribal, Alexandre Dadoun, Marco Campitiello, Francesca Plastino, Pierre‐Olivier Legros, Nathalie Marcon, Paul Coppo, Julie Egea   +9 more
wiley   +1 more source

Clinical case of thrombotic microangiopathy in obstetric practice

Сеченовский вестник, 2017
Trombotic microangiopathy is heterogeneous group of the diseases united by a community of a histological and clinical implications at difference of pathogenetic mechanisms, presents clinical-morphological syndrome characterizing a lesion of vessels of a ...
M. N. Mochalova, T. E. Belokrinitskaya, T. V. Haven, E. M. Shifman, K. G. Shapovalov, S. V. Kostromitin   +5 more
doaj  

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report [PDF]

, 2015
INTRODUCTION: Thrombotic microangiopathies are a group of diseases presenting as microangiopathic hemolytic anemia, thrombocytopenia and end-organ dysfunction.
Abdulkadir Unsal, Cuneyt Akgol, David Kavanagh, Ekrem Kara, Elbis Ahbap, Mustafa Sevinc, Tamer Sakaci, Taner Basturk, Tim HJ Goodship, Tuncay Sahutoglu, Vicky Brocklebank, Yener Koc   +11 more
core   +1 more source

Therapeutic Plasma Exchange: Analysis of Practices and Compliance With International Guidelines

Journal of Clinical Apheresis, Volume 40, Issue 2, April 2025.
ABSTRACT Therapeutic plasma exchange (TPE) is widely used in the treatment of autoimmune diseases and hematological emergencies. It is also applied in transplant patients for the desensitization of anti‐HLA (human leukocyte antigen) antibodies and the management of antibody‐mediated rejection.
Davi Mesquita Miranda, Marina Vilela Pires Coelho, Márcia Torresan Delamain, Raquel A. Fabreti‐Oliveira   +3 more
wiley   +1 more source

A Case of Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome

Annals of Internal Medicine: Clinical Cases
Atypical hemolytic uremic syndrome (aHUS) is a rare non-Shiga toxin thrombotic microangiopathy caused by uncontrolled activation of the alternative complement pathway.
Kwasi Opare-Addo, Sammudeen Ibrahim, Basilio Addo, Jorge Chancay Rodriguez   +3 more
doaj   +1 more source